Search
Filter Results
Displaying 791–800 of 833 for “retinal diseases”
-
Jun 15, 2021
Biogen’s Phase 3 Clinical Trial for its Choroideremia Gene Therapy Doesn’t Meet Endpoints
Additional results from the trial will be reported at a future scientific meeting
-
Apr 14, 2021
American Banker dubbed her as “the sharpest mind analyzing banking policy today – maybe ever.”
-
Jan 7, 2021
REGENXBIO’s Wet AMD Gene Therapy Moving into Phase 3 Trials
In a Phase ½ clinical trial, the emerging treatment reduced the burden of regular anti-VEGF injections
-
Welcome to our livestream series, Music to Our Eyes. In each episode, we sit down with various artists to discuss their experiences with vision loss and discuss their commitment to creating music that celebrates diversity and belonging.
-
Oct 5, 2020
The Dutterers Aren't Afraid to Share Their Story
Steve and Dot Dutterer have kind and approachable personalities that captivate everyone they meet. With their expansive network, and a lot of hard work and dedication over the past 19 years, Steve and Dot have raised more than $743,000 for the Foundation through the Baltimore VisionWalk.
-
Bronze Partner - Janssen Pharmaceutical Companies
Bronze Partner - Janssen Pharmaceutical Companies
-
May 28, 2020
Genentech’s Port Delivery System for Wet AMD Meets Primary Endpoint in Phase 3 Clinical Trial
Tiny implant provides continual delivery of anti-VEGF treatment for six months
-
May 15, 2020
Positive Interim Clinical Trial Results for Adverum’s Wet AMD Gene Therapy
The gene therapy is designed to reduce the treatment burden for patients
-
Mar 31, 2020
The Foundation Fighting Blindness is closely monitoring the COVID-19 situation and its impact on the IRD community.
-
There are several ways you can donate to the Foundation Fighting Blindness and receive an income stream for the rest of your life.